title: Reversible hair depigmentation in a patient treated with imatinib.
authors.forename: Stefania
authors.initials: S
authors.lastname: Mariani
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Abruzzese
authors.forename: Sabrina
authors.initials: S
authors.lastname: Basciani
authors.forename: Daniela
authors.initials: D
authors.lastname: Fiore
authors.forename: Agnese
authors.initials: A
authors.lastname: Persichetti
authors.forename: Mikiko
authors.initials: M
authors.lastname: Watanabe
authors.forename: Giovanni
authors.initials: G
authors.lastname: Spera
authors.forename: Lucio
authors.initials: L
authors.lastname: Gnessi
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001549:Benzamides; D006200:Hair Color / Q000187:drug effects; D006201:Hair Diseases / Q000139:chemically induced*; D006801:Humans; D017496:Hypopigmentation / Q000139:chemically induced*; D000068877:Imatinib Mesylate; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate